Terazosin Hydrochloride Anhydrous (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Terazosin Hydrochloride Anhydrous drug offered from Mylan Pharmaceuticals Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | terazosin hydrochloride anhydrous |
| SUBSTANCE NAME: | TERAZOSIN HYDROCHLORIDE ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2000-02-22 |
| END MARKETING DATE: | 0000-00-00 |
Terazosin Hydrochloride Anhydrous HUMAN PRESCRIPTION DRUG Details:
| Item Description | Terazosin Hydrochloride Anhydrous from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2000-02-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-1570_2ef2542c-d0fa-429d-9c96-cc3273586888 |
| PRODUCT NDC: | 0378-1570 |
| APPLICATION NUMBER: | ANDA075140 |
Other TERAZOSIN HYDROCHLORIDE ANHYDROUS Pharmaceutical Manufacturers / Labelers:
